Karyopharm Therapeutics
Kathleen Martyn, M.S. has extensive experience in clinical research and healthcare operations, currently serving as an Associate Clinical Research Manager/Lead and Clinical Sample Operation Specialist at Karyopharm Therapeutics Inc. since August 2020. Prior roles include a Microbiology Teaching Assistant at Merrimack College and a Graduate Fellow at Whittier Rehabilitation. Kathleen also gained administrative and project coordination experience as an Administrative Assistant at Massachusetts General Hospital, supporting the Senior Administrative Director of International Advisory Services. Additional roles include research assistantships and patient care coordination. Educational qualifications include a Master of Science in Health and Wellness Management and a Bachelor’s Degree in Nutrition Sciences, both from Merrimack College.
This person is not in any teams
This person is not in any offices
Karyopharm Therapeutics
13 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).